StockBased Compensation - Omnibus Incentive Plan (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Weighted- Average Remaining Contractual Term (in Years)
Balance (in years)	4 years 21 days	4 years 7 months 24 days
Granted (in years)	6 years 3 months 3 days
Weighted-Average Remaining Contractual Term (in Years): Options vested and exercisable	3 years 7 months 13 days
Weighted-Average Remaining Contractual Term (in Years): Options vested and expected to vest	4 years 21 days
Omnibus Plan
Stock based compensation
Number of shares authorized	2,200,000
Omnibus Plan | Stock Options
Stock based compensation
Number of shares available for grant	111,737
Stock options granted (in shares)	139,648
Granted (in dollars per share)	$ 22.23
Total fair value of options vested	$ 1,200	$ 1,000
Outstanding (in shares)	909,438	780,623
Exercise price (in dollars per share)	$ 18.79	$ 18.12
Stock option life (in years)	7 years
Number of shares
Balance at beginning of year (in shares)	780,623
Granted (in shares)	139,648
Exercised (in shares)	(8,295)
Expired (in shares)	(1,409)
Forfeited (in shares)	(1,129)
Balance at end of year (in shares)	909,438	780,623
Options: Options vested and exercisable	749,317
Options: Options vested and expected to vest	909,438
Weighted-Average Exercise Price
Balance at beginning of year (in dollars per share)	$ 18.12
Granted (in dollars per share)	22.23
Exercised (in dollars per share)	12.36
Expired (in dollars per share)	23.72
Forfeited (in dollars per share)	20.09
Balance at end of year (in dollars per share)	18.79	$ 18.12
Weighted-Average Exercise Price: Options vested and exercisable	18.26
Weighted-Average Exercise Price: Options vested and expected to vest	$ 18.79
Number of unvested options scheduled to vest
Non-Vested Options as of beginning of period	100,059
Granted (in shares)	139,648
Vested (in shares)	(78,457)
Forfeited (in shares)	(1,129)
Non-Vested Options as of end of period	160,121	100,059
Weighted-Average Grant Date Fair Value
Non-Vested, beginning balance	$ 6.02
Granted: Weighted-Average Grant Date Fair Value	11.21	$ 8.99
Vested: Weighted-Average Grant Date Fair Value	15.19
Forfeited: Weighted-Average Grant Date Fair Value	12.09
Non-Vested, ending balance	$ 10.92	$ 6.02
Valuation Assumptions:
Expected term in years	2 years 10 months 24 days	4 years 3 months
Volatility (as a percent)	73.16%	77.58%
Risk-free interest rate	4.46%	2.86%
Dividend yield (as a percent)	0.00%	0.00%
Granted: Weighted-Average Grant Date Fair Value	$ 11.21	$ 8.99
Aggregate intrinsic value of stock option awards outstanding	$ 6,482	$ 15,902
Aggregate intrinsic value of stock option awards vested and exercisable	6,326
Aggregate intrinsic value of stock option awards vested and expected to vest	$ 6,482
2021 | Omnibus Plan | Stock Options
Number of unvested options scheduled to vest
Non-Vested Options as of end of period	160,121
Valuation Assumptions:
Term of award	P7Y
Vesting period	2 years